FDA Approved: HARVONI — Original Application (Gilead Sciences, Inc)

View source ↗

Summary

The FDA approved Harvoni (ledipasvir and sofosbuvir) from Gilead as an original application for the treatment of hepatitis C virus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)

Snippet

ORIG AP for HARVONI (LEDIPASVIR AND SOFOSBUVIR)